Drug Discovery World

JANUARY 10, 2023

Our catalog of over 6,500+ primary antibodies, 1,200+ secondary antibodies, and 50+ ELISA kits includes reagents for multiplex IF, flow cytometry, and more in fields including immunology, oncology, and neuroscience. Antibody validation. For many of our clients, we realise that cutting-edge research requires custom solutions.

Antibody 52

Antibody Protein Reagent Scientist 52

pharmaphorum

AUGUST 16, 2020

“Driven by technological advances and the development of precision medicines, these modernization initiatives are designed to propel laboratory efficiencies into the future, allowing scientists to spend more time on science. Reorder reagents. Open equipment service ticket. Indicate equipment availability. Trigger a video call.

Life Science 128

Life Science Reagent Scientist Clinical Trials 128

pharmaphorum

JANUARY 25, 2022

The Toronto-based company already counts many of the world’s largest pharma companies among its customers, using its platform for a range of tasks such as improving reagent and antibody selection to help scientists run more successful experiments, drawing on data from published studies and organisations’ internal databases.

Life Science 52

Life Science Pharma Companies Reagent Scientist 52

Drug Discovery World

SEPTEMBER 29, 2022

During a 2021 webinar on optimising assay development for hit identification, a survey asked over 50 drug discovery scientists, “Which goal is the highest priority when developing a drug discovery assay?”. Minimising reagent consumption and costs. Generating robust, reproducible data generating confidence in results.

Reagent 52

Reagent DNA Scientist Drugs 52

XTalks

JUNE 27, 2022

BD says it offers a “suite of open system reagents for the BD MAX System that enables labs to fully automate and streamline their Lab Developed Tests, and BD can partner with customers to develop complementary assays on the system.”.

Development 83

Development In-Vitro Reagent Vaccination 83

Drug Discovery World

SEPTEMBER 14, 2023

Valuable scientists may also become bored and look for more exciting work elsewhere that makes better use of their education and skills. If you perform all of your tasks manually, you may need to stop your initial run partway through, which means losing the reagents and samples with which you have already begun working.

Reagent 111

Reagent Life Science Scientist DNA 111

Drug Discovery World

JUNE 28, 2023

Valuable scientists may also become bored and look for more exciting work elsewhere that makes better use of their education and skills. If you perform all of your tasks manually, you may need to stop your initial run partway through, which means losing the reagents and samples with which you have already begun working.

Reagent 98

Reagent Life Science Scientist DNA 98

XTalks

AUGUST 18, 2020

Instead of RNA extraction, the Yale test involves use of a reagent that when mixed with a saliva sample and heated for a short period of time, releases the viral genome for subsequent detection with PCR. Having a test that requires less reagents and resources, such as the RNA extraction kits, increases capabilities for increased testing.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

Drug Discovery World

FEBRUARY 16, 2023

Their technologies range from data sciences to cell sciences, reagents to robotics, and microfluidics to virtual reality. In the ‘post-Covid’ era (or perhaps ‘managed-Covid era’ is more accurate), the work of these data scientists fits comfortably within established remote or hybrid work settings.

Life Science 52

Life Science Research Reagent Production 52

Pharmaceutical Technology

FEBRUARY 3, 2023

With scientists fervently developing mRNA vaccines, nucleic acid therapeutics, and viral vector-based gene therapies, clinicians are set to have a growing number of tools available to treat a wide range of conditions, from infectious diseases to genetic disorders and more. The field of genomic medicine has reached a true turning point.

Genome 244

Genome Genomics Medicine Gene Therapy 244

XTalks

OCTOBER 1, 2020

Leaving academia for industry is a route that academic scientists and professors did not traditionally pursue in the past due to perceived differences in skillsets, experiences and even associated stigmas. WeiQi Lin, MD, PhD, executive vice president of research & development and principal scientist, DURECT Corporation.

Scientist 52

Scientist In-Vitro Research Life Science 52

Drug Discovery World

NOVEMBER 28, 2023

Scientists at the University of Bath have developed a way of joining up the head and tail of a protein, making it more stable and easier to get into cells. As such, the scientists at the University of Bath have developed a way to get around this problem. It is therefore much simpler and cheaper.

Protein 59

Protein Drugs Reagent Life Science 59

Advarra

NOVEMBER 29, 2022

Bottlenecks in the manufacturing process, supply chain issues such as accessibility of good manufacturing practice (GMP)-grade reagents, and shortages of qualified scientists and engineers have caused many therapies to fail at critical stages of the clinical development pipeline. But review issues are not the only problems.

Gene Therapy 52

Gene Therapy Gene Production Clinical Trials 52

Drug Discovery World

APRIL 3, 2023

As a business of scientists, we remain passionate about the exciting developments in the industry, from research to precision therapies, and insatiably curious about the new possibilities that can be achieved by overcoming the limits of standard research tools and methods. To what do you attribute your success?

Antibody 52

Antibody Gene Therapy Gene In-Vitro 52

Pharmaceutical Technology

APRIL 28, 2023

Its scope includes Syngene providing integrated drug discovery and development solutions in discovery chemistry and biology, peptide chemistry, antibody and protein reagents, pharmacokinetics and drug metabolism, and pharmaceutical development. until 2026. Profile Syngene International Ltd.

Manufacturing 130

Manufacturing Antibody Clinical Supply Protein 130

The Pharma Data

JANUARY 22, 2021

The Biden team said it had identified 12 “immediate supply shortfalls” that have been critical to the pandemic response, including N95 surgical masks and isolation gowns, as well as swabs, reagents and pipettes used in testing, the Times reported. COVID variants might lessen power of vaccines.

Vaccination 52

Vaccination Vaccine Antibody Reagent 52

Drug Discovery World

AUGUST 22, 2022

In this webinar, Christina Pettus, Senior Scientist, Charles River Laboratories, provides insights into how the company incorporates Octet® Bio-Layer Interferometry (BLI) into its monoclonal antibody discovery workflow for discovery campaigns, antibody optimisation, and IgG characterisation.

Antibody 52

Antibody Reagent Engineer Protein 52

Drug Discovery World

AUGUST 30, 2022

In this webinar, Christina Pettus, Senior Scientist, Charles River Laboratories, provides insights into how the company incorporates Octet Bio-Layer Interferometry (BLI) into its monoclonal antibody discovery workflow for discovery campaigns, antibody optimisation, and IgG characterisation.

Antibody 52

Antibody Reagent Protein Scientist 52

Drug Discovery World

SEPTEMBER 20, 2022

In this webinar, Christina Pettus, Senior Scientist, Charles River Laboratories, provides insights into how the company incorporates Octet Bio-Layer Interferometry (BLI) into its monoclonal antibody discovery workflow for discovery campaigns, antibody optimisation, and IgG characterisation.

Antibody 52

Antibody Reagent Protein Scientist 52

Drug Discovery World

AUGUST 22, 2022

In this webinar, Christina Pettus, Senior Scientist, Charles River Laboratories, provides insights into how the company incorporates Octet® Bio-Layer Interferometry (BLI) into its monoclonal antibody discovery workflow for discovery campaigns, antibody optimisation, and IgG characterisation.

Antibody 52

Antibody Reagent Engineer Protein 52

The Pharma Data

JANUARY 27, 2021

Bruker is one of the world’s leading analytical instrumentation companies providing high-performance scientific instruments and high-value analytical and diagnostic solutions to scientists globally. 28, 2021 09:19 UTC. CAMBRIDGE & WETHERBY, England & BILLERICA, Mass.–(

Reagent 52

Reagent In-Vitro FDA Approval Development 52

pharmaphorum

FEBRUARY 3, 2021

Dr Jennifer Harbottle, senior scientist in the R&D Base Editing team of PerkinElmer’s Horizon Discovery business, looks at progress made in the realms of biotechnology and next-generation diagnostics, vaccines and therapeutics, including the application of CRISPR-Cas9 gene editing in developing and refining cell therapies.

Gene Editing 98

Gene Editing Gene DNA Engineer 98

Drug Discovery World

APRIL 13, 2023

Anything you can do to reduce costs is good – and savings on reagents are clearly a key driver for labs to miniaturise. When you try to scale down the volumes used in these methods, you soon run into a host of challenges around certain reagent types, different liquid viscosities, and tricky tasks such as bead clean-ups.

Genome 52

Genome Genomics Reagent Development 52

Drug Discovery World

DECEMBER 13, 2023

Moreover, custom antibodies are a key reagent in companion diagnostics for these novel therapeutics. Whatever your target and application, our scientists partner closely with your team to validate an antibody for your specific assay and its unique requirements.

Life Science 59

Life Science Antibody Manufacturing In-Vivo 59

Drug Discovery World

NOVEMBER 30, 2023

coli expression systems and is using high-throughput expression pipelines to screen constructs for optimal expression to generate protein and cellular reagents. The Absolute Antibody team was available to discuss custom services, as well as the company’s comprehensive antibody reagent catalogue.

Antibody 59

Antibody Protein Engineer In-Vivo 59

Drug Discovery World

OCTOBER 11, 2022

Earlier this year, I shared a stage with Dr. Helena Peilot Sjögren , Associate Principal Scientist in Discovery Biology at AstraZeneca, as we made a joint presentation at SLAS. Using HDE, one AstraZeneca team found a way to run an assay with 50% less of a highly expensive reagent. And it’s going to happen sooner than you think.

Life Science 52

Life Science Scientist Engineer Development 52

Drug Discovery World

FEBRUARY 27, 2023

By focusing on workflow simplification and expanded assay capabilities in a state-of-the-art microplate reader, complemented by our optimised reagent technologies, our team has created an all-around high-performing system built for today and the future.”

Drugs 52

Drugs Life Science Protein Scientist 52

XTalks

APRIL 22, 2022

Receptor occupancy assays have been developed and applied in both nonclinical and clinical studies to provide insight into PK/PD relationships so far,” said Andre Olsson, PhD, Senior Scientist, Flow Cytometry at the global contract research organization (CRO) Medpace. The Benefits of Receptor Occupancy in Clinical Trials.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Antibody 98

XTalks

JANUARY 20, 2021

Access to laboratory reagents, equipment and research subjects is a necessity for researchers to complete their experimental work, as well as care for live cells, plants or animals. To keep these workers safe, employers have implemented social distancing protocols in the workplace, for employees and customers alike.

Research 97

Research Reagent Marketing Packaging 97

Drug Discovery World

OCTOBER 12, 2022

This initial work, which was published in Analytical Biochemistry and co-authored by scientists from both NIBRT and Agilent (Xie et al, 2021), includes the analysis of glycan profiles of two mAbs, human polyclonal antibodies and the total protein in human serum. The glycan database .

Protein 52

Protein Gene Therapy Antibody Production 52

Drug Discovery World

JULY 18, 2023

Nucleic acid-based diagnostics, which typically require PCR reagents and laboratory equipment, are crucial for identifying, treating, and preventing common infectious diseases. To address these issues, scientists are developing alternative CRISPR-based approaches that avoid DSBs, such as base editing and prime editing.

DNA 98

DNA Genome Genomics RNA 98

Drug Discovery World

MARCH 13, 2023

Before 2019, CGT drug developers still had a young, academic mindset, ordering reagents, materials, and equipment haphazardly and assuming they would show up when needed. About the author Lauren Collison is an established scientist and researcher with over 15 years of experience in cellular immunology.

Gene Therapy 52

Gene Therapy Gene Manufacturing Development 52

Drug Discovery World

AUGUST 12, 2022

By selecting the correct salt form for an assay or as a reagent, scientists can optimise their research projects, says Andrievs Auseklis Auzin, Developer, Molport, Latvia. These can have better properties than their parents, including preferable stability, solubility, bioavailability, and manufacturability.

Drugs 52

Drugs Bioassay Development Research 52

Drug Discovery World

FEBRUARY 15, 2023

Reagents that can augment and enhance ADCC are of interest in addition to the antibodies themselves. An experienced life science research scientist, Singh has over 18 years’ academic and commercial experience across diagnostics, pharmaceutical, and the biotech/biomedical sectors.

Research 52

Research In-Vitro In-Vivo Development 52

Drug Discovery World

OCTOBER 20, 2022

Dr Amber Miller, Flow Cytometry Scientist, Fortis Life Sciences, says flow cytometry techniques can help our understanding of cancer associated fibroblasts but there is still work to be done. Data analysis is more complex for mass cytometry and imaging mass cytometry because of the number of parameters assessed in each sample. doi:10.1016/j.

Antibody 52

Antibody In-Vivo Life Science Development 52

Drug Discovery World

OCTOBER 14, 2022

Arndt Aspe r ger , Senior Applications Scientist , Bruker Daltonics and M ei ke Hamester , Vice President Label-Free Technologies , Bruker Daltonics , examine how challenges in mass spectrometry for high-throughput screening can be overcome using a label-free approach. . Overcoming challenges in HTS using mass spectrometry .

Drugs 52

Drugs In-Vitro Development Production 52

Drug Discovery World

JUNE 14, 2023

In addition to the collection, processing and storing of adult blood projects, BCA is also involved in providing umbilical cord blood and other tissue products as critical components of cell therapies.

Manufacturing 52

Manufacturing Production Gene Therapy Development 52